Catelani Michael bought ANIX
January 2, 2025 · Form 4 insider transaction
Catelani Michael bought 350,000 shares of Anixa Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
350,000
Price
$0.00
Total value
N/A
InsiderCatelani Michael
Role—
SecurityEmployee Stock Option
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2025
Filing dateJanuary 3, 2025
Shares owned after350,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.; The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025.